
A turning point for human-based drug discovery
Daniel Delubac, Chief Executive Officer at iOrganBio looks at how technologies that mimic human behaviour can improve drug discovery efforts past animal models. The US is signalling a decisive shift toward human-based drug discovery. In March, the National Institutes of Health (NIH) announced a $150 million investment to support the development of novel approaches that mimic human biology to reduce… Read More













